Philips Introduces SmartIQ for Enhanced Coronary Imaging With Lower Radiation
AMSTERDAM, Netherlands, May 18, 2026 Royal Philips has introduced SmartIQ, a breakthrough AI-enabled coronary imaging technology developed for its...
Alzheimer’s Disease ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development EMA FDA fda approval FDA clearance GCP Gene Therapy Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
AMSTERDAM, Netherlands, May 18, 2026 Royal Philips has introduced SmartIQ, a breakthrough AI-enabled coronary imaging technology developed for its...
MELBOURNE, Australia, and INDIANAPOLIS, May 15, 2026 Telix Pharmaceuticals Limited announced new strategic collaborations with EDAP TMS S.A. and...
